KAREN ANDERSEN News & Analysis

Three new vaccines for coronavirus look poised for emergency use authorisation in the US this autumn. What does that mean for investors?

Diagnostic testing, treatment, and a coronavirus vaccine could allow near-normal distancing and nonessential business recovery by mid-2021.

Diagnostics, treatment, and vaccine progress could allow near-normal distancing and nonessential business recovery by mid-2021, Morningstar says.

Morningstar healthcare strategist Karen Andersen has increased her fair value estimate for the wide moat pharmaceutical company following positive...

Christine Benz and Karen Andersen discuss Morningstar's latest views on stopping the spread of the virus as well as the economic implications.

A COVID-19 recession doesn't fit the mould of a 2008-style recession with longer-lasting economic impact.

Karen Andersen and Preston Caldwell give us their latest perspectives on healthcare and energy.

A forecast low fatality rate implies an overstated threat to the economy, says Morningstar's Karen Andersen.

Morningstar's Karen Andersen explains how environmental, social and governance issues affect Big Pharma and biotech companies.